Cantor Fitzgerald’s Inhibrx, Inc. Common Stock INBX Stock Holding History

Cantor Fitzgerald’s Portfolio INBX Stock Details INBX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-139,715	Closed	-$4.88M	–	368
2024 Q1	$4.88M	Buy	+139,715	New	+$5.1M	1.15%	14

Other funds holding INBX

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Cantor Fitzgerald's INBX Position: Q2 2024 in Review

Cantor Fitzgerald sold out of Inhibrx, Inc. Common Stock (INBX) in Q2 2024, closing a stake of 139,715 shares — an estimated $4.88M sold.

Cantor Fitzgerald first reported a position in INBX in Q1 2024 and held it in 1 quarter. The position peaked at $4.88M in Q1 2024. 2 funds tracked by Wall St. Rank hold INBX as of Q2 2024.

Cantor Fitzgerald reported no remaining Inhibrx, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Cantor Fitzgerald sold 139,715 Inhibrx, Inc. Common Stock shares in Q2 2024, an estimated $4.88M.
Cantor Fitzgerald first reported a position in Inhibrx, Inc. Common Stock in Q1 2024 and held it in 1 quarter.
Cantor Fitzgerald's Inhibrx, Inc. Common Stock position peaked at $4.88M in Q1 2024.
2 funds tracked by Wall St. Rank held Inhibrx, Inc. Common Stock as of Q2 2024.

Based on Cantor Fitzgerald's 13F filing for Q2 2024, filed 14 Aug 2024.